After months of advocacy from faith and global-health communities, Congress decided in last minute negotiations this week to ...

WHO recommends twice-yearly injectable lenacapavir for HIV prevention, expanding PrEP options for key populations.

As Black women are being hit with new HIV cases, stars such as Tamar Braxton is unapologetically shining a light on HIV ...

PEPFAR has saved more than 25 million lives since its inception. It has strengthened health systems and helped stabilize ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

The Joint United Nations Programme on HIV/Aids (UNAids) has released a report that highlights a significant funding crisis ...

A new report says the withdrawal of U.S. funding has caused a “systemic shock” to the global effort against AIDS and HIV.

A new report by the U.N. AIDS agency says the sudden withdrawal of U.S. funding has caused a “systemic shock” to the global ...

The $4 billion that the U.S. pledged for the global HIV response for 2025 disappeared virtually overnight in January when ...

Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to supply a long-acting HIV prevention drug to low-income countries, despite the ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...